InvestorsHub Logo
Followers 76
Posts 3421
Boards Moderated 0
Alias Born 03/15/2005

Re: LeGoose post# 2622

Monday, 04/04/2011 7:26:55 PM

Monday, April 04, 2011 7:26:55 PM

Post# of 27412
Also, Xigris seems to be mostly used for severe sepsis (2 or more organs failing) Perhaps CTSO might have their starting niche in the less severe (and perhaps more numerous) cases? I'm a bio-tech newbie, so please forgive my ignorance. Just trying to figure this all out.

Xigris is used in adult patients with severe sepsis. Sepsis is a condition when bacteria get into the bloodstream and produce harmful substances (toxins). The toxins cause the patient’s organs to fail, such as the heart, lungs and kidneys. Xigris is used when the patient has two or more organs failing, in addition to best standard care such as antibiotics, medicines to support the organs and treatment in a specialised unit. Xigris should be used mainly when it can be started within 24 hours of the organ failure. It is intended for short-term use.



http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000396/human_med_001160.jsp&murl=menus/medicines/medicines.jsp&jsenabled=true
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News